/5
0 avis
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial
Archive ouverte
Edité par CCSD ; Ferrata Storti Foundation -
International audience
Consulter en ligne
Chargement des enrichissements...